Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
myo-inositol + dioscorea villosa is a dietary supplement combination primarily marketed for the management of polycystic ovary syndrome (PCOS) and female hormonal imbalances. Myo-inositol, a carbocyclic sugar, functions as a second messenger in the insulin signaling pathway, helping to improve insulin sensitivity and restore ovulatory function in women with PCOS. *Dioscorea villosa*, commonly known as wild yam, contains diosgenin, a steroid sapogenin that is traditionally used to support hormonal balance and alleviate symptoms of menstrual irregularities. This combination is typically available in oral capsule form and is classified as a nutraceutical rather than a regulated pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myo-inositol + dioscorea villosa.